MORPHINE SULFATE 10 mg/1 mL MEDSURGE morphine sulfate pentahydrate 10 mg/1 mL solution for injection ampoule Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

morphine sulfate 10 mg/1 ml medsurge morphine sulfate pentahydrate 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - injection, solution - excipient ingredients: sodium chloride; hydrochloric acid; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE ORAL SOLUTION CII- morphine sulfate solution Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

morphine sulfate oral solution cii- morphine sulfate solution

nostrum laboratories, inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 100 mg in 5 ml - morphine sulfate oral solution (10 mg per 5 ml and 20 mg per 5 ml) are formulations of morphine, an opioid agonist, indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. morphine sulfate oral solution 100 mg per 5 ml (20 mg/ml) is an opioid analgesic indicated for the relief of moderate to severe acute and chronic pain in opioid-tolerant patients. morphine sulfate oral solution 100 mg per 5 ml (20 mg/ml) may cause fatal respiratory depression when administered to patients not previously exposed to opioids. patients considered to be opioid tolerant are those who are taking at least 60 mg oral morphine per day, or at least 30 mg of oral oxycodone per day, or at least 12 mg hydromorphone per day, or an equianalgesic dose of another opioid, for a week or longer. morphine sulfate is contraindicated in patients with known hypersensitivity to morphine, morphine salts, or any components of the product. morphine sulfate is contraindicated in patients

MORPHINE SULFATE 30 mg/1 mL MEDSURGE morphine sulfate pentahydrate 30 mg/1 mL solution for injection ampoule Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

morphine sulfate 30 mg/1 ml medsurge morphine sulfate pentahydrate 30 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 30 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 2 mg/1 mL MEDSURGE morphine sulfate pentahydrate 2 mg/1 mL solution for injection ampoule Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

morphine sulfate 2 mg/1 ml medsurge morphine sulfate pentahydrate 2 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 2 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 15 mg/1 mL MEDSURGE morphine sulfate pentahydrate 15 mg/1 mL solution for injection ampoule Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

morphine sulfate 15 mg/1 ml medsurge morphine sulfate pentahydrate 15 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 15 mg - injection, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE 5 mg/1 mL MEDSURGE morphine sulfate pentahydrate 5 mg/1 mL solution for injection ampoule Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

morphine sulfate 5 mg/1 ml medsurge morphine sulfate pentahydrate 5 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride; hydrochloric acid - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE MR MYLAN morphine sulfate pentahydrate 10 mg modified release tablet blister pack Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

morphine mr mylan morphine sulfate pentahydrate 10 mg modified release tablet blister pack

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; magnesium stearate; hyetellose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.

MORPHINE SULFATE 10 mg/1 mL MEDICIANZ morphine sulfate pentahydrate 10 mg/1 mL solution for injection ampoule Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

morphine sulfate 10 mg/1 ml medicianz morphine sulfate pentahydrate 10 mg/1 ml solution for injection ampoule

medsurge pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - injection, solution - excipient ingredients: hydrochloric acid; sodium chloride; water for injections - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain. may also be used as a pre-operative medication and as an analgesic adjunct in general anaesthesia.

MORPHINE SULFATE ORAL SOLUTION- morphine sulfate oral solution solution MORPHINE SULFATE- morphine sulfate solution Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

morphine sulfate oral solution- morphine sulfate oral solution solution morphine sulfate- morphine sulfate solution

nostrum laboratories, inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 10 mg in 5 ml - morphine sulfate oral solution (10 mg per 5 ml and 20 mg per 5 ml ) are formulations of morphine, an opioid agonist, indicated for the relief of moderate to severe acute and chronic pain where use of an opioid analgesic is appropriate. morphine sulfate is contraindicated in patients with known hypersensitivity to morphine, morphine salts, or any components of the product. morphine sulfate is contraindicated in patients with respiratory depression in the absence of resuscitative equipment. morphine sulfate is contraindicated in patients with acute or severe bronchial asthma or hypercarbia. morphine sulfate is contraindicated in any patient who has or is suspected of having paralytic ileus. no formal studies to assess the teratogenic effects of morphine in animals have been conducted.  it is also not known whether morphine can cause fetal harm when administered to a pregnant woman or can affect reproductive capacity.  morphine should be given to a pregnant woman only if clearly needed. in humans, the frequency

ARX MORPHINE MR morphine sulfate pentahydrate 10 mg modified release tablet blister packs Austraalia - inglise - Department of Health (Therapeutic Goods Administration)

arx morphine mr morphine sulfate pentahydrate 10 mg modified release tablet blister packs

southern cross pharma pty ltd - morphine sulfate pentahydrate, quantity: 10 mg - tablet, modified release - excipient ingredients: povidone; hypromellose; magnesium stearate; hyetellose; purified talc; lactose monohydrate; titanium dioxide; iron oxide yellow; iron oxide red; macrogol 400 - for the management of severe pain where other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain, and the pain is opioid-responsive, and requires daily, continuous, long-term treatment. is not indicated for use in chronic non-cancer pain other than in exceptional circumstances. is not indicated as an as-needed (prn) analgesia.